| Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel index and the Functional Independence Measure J Van der Putten, JC Hobart, JA Freeman, AJ Thompson Journal of Neurology, Neurosurgery & Psychiatry 66 (4), 480-484, 1999 | 525 | 1999 |
| Kurtzke scales revisited: the application of psychometric methods to clinical intuition J Hobart, J Freeman, A Thompson Brain 123 (5), 1027-1040, 2000 | 396 | 2000 |
| Treatment of progressive multiple sclerosis: what works, what does not, and what is needed A Feinstein, J Freeman, AC Lo The Lancet Neurology 14 (2), 194-207, 2015 | 344 | 2015 |
| Evidence-based measurement: which disability scale for neurologic rehabilitation? JC Hobart, DL Lamping, JA Freeman, DW Langdon, DL McLellan, ... Neurology 57 (4), 639-644, 2001 | 338 | 2001 |
| The impact of inpatient rehabilitation on progressive multiple sclerosis JA Freeman, DW Langdon, JC Hobart, AJ Thompson Annals of Neurology: Official Journal of the American Neurological …, 1997 | 327 | 1997 |
| Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community? JA Freeman, DW Langdon, JC Hobart, AJ Thompson Neurology 52 (1), 50-50, 1999 | 218 | 1999 |
| Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles A Riazi, JC Hobart, DL Lamping, R Fitzpatrick, JA Freeman, C Jenkinson, ... Journal of Neurology, Neurosurgery & Psychiatry 74 (6), 710-714, 2003 | 190 | 2003 |
| The SF-36 in multiple sclerosis: why basic assumptions must be tested J Hobart, J Freeman, D Lamping, R Fitzpatrick, A Thompson Journal of Neurology, Neurosurgery & Psychiatry 71 (3), 363-370, 2001 | 171 | 2001 |
| Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis JA Freeman, JC Hobart, DW Langdon, AJ Thompson Journal of Neurology, Neurosurgery & Psychiatry 68 (2), 150-156, 2000 | 165 | 2000 |
| Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy E Scott, M Eagle, A Mayhew, J Freeman, M Main, J Sheehan, A Manzur, ... Physiotherapy Research International 17 (2), 101-109, 2012 | 164 | 2012 |
| The development of ICF Core Sets for multiple sclerosis: results of the International Consensus Conference M Coenen, A Cieza, J Freeman, F Khan, D Miller, A Weise, J Kesselring, ... Journal of neurology 258, 1477-1488, 2011 | 137 | 2011 |
| Intra-rater and inter-rater reliability of gait measurements with CODA mpx30 motion analysis system V Maynard, AMO Bakheit, J Oldham, J Freeman Gait & posture 17 (1), 59-67, 2003 | 131 | 2003 |
| Community services in multiple sclerosis: still a matter of chance JA Freeman, AJ Thompson Journal of Neurology, Neurosurgery & Psychiatry 69 (6), 728-732, 2000 | 114 | 2000 |
| Does adding MS-specific items to a generic measure (the SF-36) improve measurement? JA Freeman, JC Hobart, AJ Thompson Neurology 57 (1), 68-74, 2001 | 111 | 2001 |
| Interferon-β1b in the treatment of secondary progressive MS: impact on quality of life JA Freeman, AJ Thompson, R Fitzpatrick, M Hutchinson, C Miltenburger, ... Neurology 57 (10), 1870-1875, 2001 | 87 | 2001 |
| Qualitative evaluation of a community peer support service for people with spinal cord injury BM Haas, L Price, JA Freeman Spinal cord 51 (4), 295-299, 2013 | 86 | 2013 |
| Improving mobility and functional independence in persons with multiple sclerosis JA Freeman Journal of neurology 248, 255-259, 2001 | 83 | 2001 |
| Is the future for clinical trials internet-based? A cluster randomized clinical trial J Litchfield, J Freeman, H Schou, M Elsley, R Fuller, B Chubb Clinical Trials 2 (1), 72-79, 2005 | 65 | 2005 |
| The prevalence, distribution, and functional importance of lower limb somatosensory impairments in chronic stroke survivors: a cross sectional observational study T Gorst, A Rogers, SC Morrison, M Cramp, J Paton, J Freeman, J Marsden Disability and rehabilitation 41 (20), 2443-2450, 2019 | 57 | 2019 |
| Physician and patient-oriented outcomes in progressive neurological disease: which to measure? JC Hobart, JA Freeman, DL Lamping Current opinion in neurology 9 (6), 441-444, 1996 | 56 | 1996 |
